BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33774198)

  • 1. Microfluidic assembly of pomegranate-like hierarchical microspheres for efflux regulation in oral drug delivery.
    Raza A; Alavi SE; Sime FB; Han FY; Roberts JA; Popat A; Falconer JR; Kumeria T
    Acta Biomater; 2021 May; 126():277-290. PubMed ID: 33774198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid CO
    Raza A; Sime FB; Cabot PJ; Roberts JA; Falconer JR; Kumeria T; Popat A
    ACS Biomater Sci Eng; 2021 May; 7(5):1836-1853. PubMed ID: 33438994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PLGA encapsulated γ-cyclodextrin-meropenem inclusion complex formulation for oral delivery.
    Raza A; Miles JA; Sime FB; Ross BP; Roberts JA; Popat A; Kumeria T; Falconer JR
    Int J Pharm; 2021 Mar; 597():120280. PubMed ID: 33540004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and characterization of metformin hydrochloride loaded-Eudragit®RSPO and Eudragit®RSPO/PLGA nanoparticles.
    Cetin M; Atila A; Sahin S; Vural I
    Pharm Dev Technol; 2013; 18(3):570-6. PubMed ID: 21864098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eudragit® L100/N-trimethylchitosan chloride microspheres for oral insulin delivery.
    Marais E; Hamman J; Plessis Ld; Lemmer R; Steenekamp J
    Molecules; 2013 Jun; 18(6):6734-47. PubMed ID: 23749161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microfluidic assembly of a nano-in-micro dual drug delivery platform composed of halloysite nanotubes and a pH-responsive polymer for colon cancer therapy.
    Li W; Liu D; Zhang H; Correia A; Mäkilä E; Salonen J; Hirvonen J; Santos HA
    Acta Biomater; 2017 Jan; 48():238-246. PubMed ID: 27815166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo comparison of microcontainers and microspheres for oral drug delivery.
    Christfort JF; Strindberg S; Al-Khalili S; Bar-Shalom D; Boisen A; Nielsen LH; Müllertz A
    Int J Pharm; 2021 May; 600():120516. PubMed ID: 33775722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and in vitro/in vivo evaluation of gliclazide loaded Eudragit nanoparticles as a sustained release carriers.
    Devarajan PV; Sonavane GS
    Drug Dev Ind Pharm; 2007 Feb; 33(2):101-11. PubMed ID: 17454041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of magnesium stearate on the physicochemical and pharmacodynamic characteristics of insulin-loaded Eudragit entrapped mucoadhesive microspheres.
    Momoh MA; Kenechukwu FC; Nnamani PO; Umetiti JC
    Drug Deliv; 2015; 22(6):837-48. PubMed ID: 24670092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enteric microsphere formulations of papain for oral delivery.
    Sharma M; Sharma V; Panda AK; Majumdar DK
    Yakugaku Zasshi; 2011; 131(5):697-709. PubMed ID: 21532266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salmon calcitonin-loaded Eudragit® and Eudragit®-PLGA nanoparticles: in vitro and in vivo evaluation.
    Cetin M; Aktas MS; Vural I; Ozturk M
    J Microencapsul; 2012; 29(2):156-66. PubMed ID: 22126314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efflux ratio cannot assess P-glycoprotein-mediated attenuation of absorptive transport: asymmetric effect of P-glycoprotein on absorptive and secretory transport across Caco-2 cell monolayers.
    Troutman MD; Thakker DR
    Pharm Res; 2003 Aug; 20(8):1200-9. PubMed ID: 12948018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ranitidine Hydrochloride-loaded Ethyl Cellulose and Eudragit RS 100 Buoyant Microspheres: Effect of pH Modifiers.
    Kotagale NR; Parkhe AP; Jumde AB; Khandelwal HM; Umekar MJ
    Indian J Pharm Sci; 2011 Nov; 73(6):626-33. PubMed ID: 23112396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A quality by design (QbD) study on enoxaparin sodium loaded polymeric microspheres for colon-specific delivery.
    Hales D; Vlase L; Porav SA; Bodoki A; Barbu-Tudoran L; Achim M; Tomuță I
    Eur J Pharm Sci; 2017 Mar; 100():249-261. PubMed ID: 28088371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Eudragit® Retard Polymers for the Microencapsulation of Alpha-Lipoic Acid.
    Pecora TM; Musumeci T; Musumeci L; Fresta M; Pignatello R
    Curr Drug Deliv; 2016; 13(7):1165-1175. PubMed ID: 26472468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Insight into Eudragit S100 Preserving Mechanism of Cinnarizine Supersaturation.
    Maghsoodi M; Astemal SM; Nokhodchi A; Kiaie H; Khoshfetrat AB; Talebi F
    AAPS PharmSciTech; 2022 Mar; 23(3):80. PubMed ID: 35233687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Vitro Characterization, Modelling, and Antioxidant Properties of Polyphenon-60 from Green Tea in Eudragit S100-2 Chitosan Microspheres.
    Souto EB; da Ana R; Souto SB; Zielińska A; Marques C; Andrade LN; Horbańczuk OK; Atanasov AG; Lucarini M; Durazzo A; Silva AM; Novellino E; Santini A; Severino P
    Nutrients; 2020 Mar; 12(4):. PubMed ID: 32244441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cationic Eudragit® polymers as excipients for microparticles prepared by solvent evaporation method.
    Vysloužil J; Bavoľárová J; Kejdušová M; Vetchý D; Dvořáčková K
    Ceska Slov Farm; 2013 Dec; 62(6):249-54. PubMed ID: 24393112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eudragit S100-Coated Chitosan Nanoparticles Co-loading Tat for Enhanced Oral Colon Absorption of Insulin.
    Chen S; Guo F; Deng T; Zhu S; Liu W; Zhong H; Yu H; Luo R; Deng Z
    AAPS PharmSciTech; 2017 May; 18(4):1277-1287. PubMed ID: 27480441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of plasticizer level on the drug release from sustained release film coated and hot-melt extruded dosage forms.
    Zhu Y; Mehta KA; McGinity JW
    Pharm Dev Technol; 2006; 11(3):285-94. PubMed ID: 16895839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.